HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Lewis B Morgenstern Selected Research
Lewis B Morgenstern Research Topics
Disease
61
Stroke (Strokes)
10/2023 - 01/2002
18
Ischemic Stroke
10/2020 - 05/2002
7
Cerebral Hemorrhage
04/2015 - 01/2004
6
Hypertension (High Blood Pressure)
07/2020 - 06/2003
4
Atrial Fibrillation
01/2020 - 03/2011
3
Sleep Apnea Syndromes (Sleep Apnea)
10/2020 - 11/2013
3
Transient Ischemic Attack
10/2020 - 03/2015
2
Cognitive Dysfunction
11/2023 - 01/2022
2
Myocardial Infarction
01/2021 - 06/2005
2
Obstructive Sleep Apnea
10/2020 - 06/2005
2
Cardiovascular Diseases (Cardiovascular Disease)
10/2018 - 06/2005
2
Aneurysm (Aneurysms)
12/2010 - 05/2007
2
Intracranial Aneurysm (Cerebral Aneurysm)
12/2010 - 01/2008
2
Brain Edema (Cerebral Edema)
02/2010 - 05/2009
2
Brain Injuries (Brain Injury)
06/2009 - 05/2009
1
Diabetes Mellitus
01/2020
1
Carotid Stenosis (Carotid Artery Stenosis)
11/2019
1
Pathologic Constriction (Stenosis)
11/2019
1
Infarction (Infarctions)
02/2015
1
Apnea
11/2013
1
Paresthesia (Dysesthesia)
12/2010
1
Inflammation (Inflammations)
12/2010
1
Dizziness (Lightheadedness)
11/2010
1
Heart Diseases (Heart Disease)
06/2010
1
Dementia (Dementias)
06/2010
1
Atrophy
02/2010
1
Hemorrhage
10/2009
1
Hematoma
06/2009
1
Ventricular Fibrillation
05/2008
1
Heart Arrest (Cardiac Arrest)
05/2008
1
Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
05/2007
1
Hemorrhagic Stroke
06/2003
1
Metrorrhagia (Spotting)
10/2002
1
Infections
01/2002
1
Hypothermia
01/2002
1
Hyperthermia
01/2002
Drug/Important Bio-Agent (IBA)
20
Tissue Plasminogen Activator (Alteplase)
FDA Link
01/2019 - 05/2002
4
Deferoxamine (Desferal)
FDA Link
Generic
11/2011 - 05/2009
3
Particulate Matter
IBA
11/2017 - 11/2015
3
Ozone
IBA
11/2017 - 11/2015
3
Warfarin (Coumadin)
FDA Link
Generic
02/2014 - 10/2010
2
Indicators and Reagents (Reagents)
IBA
01/2020 - 03/2010
2
Cholesterol
IBA
01/2020 - 01/2019
2
Environmental Pollutants (Pollutants, Environmental)
IBA
11/2017 - 07/2008
2
Air Pollutants (Pollutants, Air)
IBA
01/2017 - 11/2015
2
Iron
IBA
11/2011 - 06/2009
2
Caffeine (No Doz)
FDA Link
Generic
09/2005 - 06/2003
1
Antihypertensive Agents (Antihypertensives)
IBA
07/2020
1
Creatinine
IBA
11/2019
1
Antidepressive Agents (Antidepressants)
IBA
01/2019
1
Anticoagulants
IBA
01/2017
1
Dietary Sodium
IBA
09/2016
1
danaparoid (Orgaran)
FDA Link
02/2015
1
Plasminogen
IBA
07/2014
1
Placebos
IBA
11/2013
1
salicylhydroxamic acid (SHAM)
IBA
11/2013
1
Immunoglobulin G (IgG)
IBA
01/2013
1
antineoplaston A10 (A 10)
IBA
08/2012
1
Chelating Agents
IBA
11/2011
1
poly(lactide) (polylactic acid)
IBA
12/2010
1
peptide-Gly-Leu-amide
IBA
12/2010
1
Apolipoproteins
IBA
06/2010
1
Apolipoproteins E (ApoE)
IBA
06/2010
1
Lipids
IBA
05/2010
1
Buffers
IBA
08/2009
1
Aminocaproic Acid (6 Aminocaproic Acid)
FDA Link
Generic
01/2004
1
Cocaine (Cocaine HCl)
IBA
06/2003
1
Nicotine
FDA Link
06/2003
1
Acetaminophen (Paracetamol)
FDA Link
Generic
01/2002
Therapy/Procedure
12
Activities of Daily Living (ADL)
11/2023 - 04/2014
12
Therapeutics
05/2013 - 01/2002
4
Resuscitation Orders (Do Not Resuscitate Orders)
01/2019 - 10/2009
3
Carotid Endarterectomy
01/2021 - 01/2008
3
Continuous Positive Airway Pressure
10/2020 - 06/2005
3
Contraindications
10/2020 - 01/2002
3
Length of Stay
01/2020 - 11/2010
2
Stents
10/2016 - 12/2010
2
Home Nursing (Nursing, Home)
03/2015 - 10/2009
2
Emergency Treatment
05/2007 - 05/2007
2
Intravenous Administration
05/2007 - 05/2007
1
Patient Transfer (Patient Dumping)
12/2022
1
Terminal Care (Care, Terminal)
01/2020
1
Secondary Prevention
10/2018
1
Stroke Rehabilitation
01/2018
1
Aftercare (After-Treatment)
01/2017
1
Thrombectomy
10/2016
1
Treatment Delay
08/2011
1
Continuity of Patient Care
07/2011
1
Retreatment
12/2010
1
Induced Hypothermia
05/2008
1
Craniotomy
01/2008
1
Time-to-Treatment
05/2007
1
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
06/2005
1
Ligation
10/2002